Cargando…

Non-Cryoprecipitation Separation of Coagulation FVIII and Prothrombin Complex Proteins by Pseudoaffinity Calcium Elution Chromatography Using Anion Exchange Resin

Hemophilia A is treated with human plasma coagulation factor VIII (FVIII) replacement therapy and Hemophilia B with coagulation factor IX, which is purified from prothrombin complex concentrate (PCC). In this paper we evaluated the separation of FVIII and PCC by directly loading raw thawed plasma to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feliciano, Gabriel Pinna, Arimori, Sara Hayama, Nakao, Vinicius Watanabe, Dos Santos, Joice Rodrigues, Martins, Elizabeth A. L., Bemquerer, Marcelo Porto, Cheng, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607535/ https://www.ncbi.nlm.nih.gov/pubmed/36297304 http://dx.doi.org/10.3390/ph15101192

Ejemplares similares

Purification of prothrombin complex proteins from human plasma in anion exchange resin using pseudoaffinity chromatography
por: Nakao, Vinicius Watanabe, et al.
Publicado: (2014)

FVIII inhibitors display FV‐neutralizing activity in the prothrombin time assay
por: Arsiccio, Andrea, et al.
Publicado: (2021)

Cryoprecipitate therapy
por: Nascimento, B., et al.
Publicado: (2014)

Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate
por: Stanford, Sophia, et al.
Publicado: (2023)

In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
por: Hemşinlioğlu, Cansu, et al.
Publicado: (2023)

Factors affecting the quality of cryoprecipitate
por: Subramaniyan, Rajeswari, et al.
Publicado: (2017)

Perioperative Cryoprecipitate Waste Reduction
por: Burk, Camden, et al.
Publicado: (2021)

Use of Cryoprecipitate in Newborn Infants
por: Tyagi, Manvi, et al.
Publicado: (2023)

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate
por: SHIBAHASHI, Keita, et al.
Publicado: (2019)

STUDIES ON BLOOD COAGULATION : I. THE RÔLE OF PROTHROMBIN AND OF PLATELETS IN THE FORMATION OF THROMBIN
por: Eagle, Harry
Publicado: (1935)

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
por: Schöchl, Herbert, et al.
Publicado: (2017)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
por: Triulzi, D. J., et al.
Publicado: (1990)

Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors
por: Bravo, M I, et al.
Publicado: (2014)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice
por: Afraz, Sajjad, et al.
Publicado: (2022)

Autologous Cryoprecipitate for Attaching Conjunctival Autografts after Pterygium Excision
por: Anbari, Anas A.
Publicado: (2013)

Intrinsic differences between FVIIIa mimetic bispecific antibodies and FVIII prevent assignment of FVIII‐equivalence
por: Leksa, Nina C., et al.
Publicado: (2019)

THE FACTORS OF COAGULATION IN THE EXPERIMENTAL APLASTIC ANEMIA OF BENZOL POISONING, WITH SPECIAL REFERENCE TO THE ORIGIN OF PROTHROMBIN
por: Hurwitz, S. H., et al.
Publicado: (1915)

P1682: MTHFR C677T GENOTYPE IN CORRELATION WITH THROMBOSIS AND ASSOCIATION WITH FVIII COAGULANT ACTIVITY IN GREEK PAEDIATRIC POPULATION
por: Saslis, S., et al.
Publicado: (2022)

Resin-based composite materials: elution and pollution
por: Mulligan, Steven, et al.
Publicado: (2022)

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate
por: Collins, P. W., et al.
Publicado: (2014)

A retrospective review of cryoprecipitate transfusion practice in Kuala Lumpur Hospital
por: Iliassa, Intan Iliana, et al.
Publicado: (2016)

Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate
por: Drinkhouse, Macy, et al.
Publicado: (2018)

Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
por: Nguyen, S., et al.
Publicado: (2019)

Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells
por: Lubich, Christian, et al.
Publicado: (2022)

Effect of Adhesive Resin as a Modeling Liquid on Elution of Resin Composite Restorations
por: Maalekipour, Mohammadreza, et al.
Publicado: (2021)

Dose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification
por: Hashimoto, Hideki, et al.
Publicado: (2017)

Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding
por: Schreuder, Mark, et al.
Publicado: (2019)

Prothrombin Complex Concentrates to Treat Coagulation Disturbances: An Overview With a Focus on Use in Infants and Children
por: Munlemvo, Dolly M., et al.
Publicado: (2022)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line
por: Hounkpe, Bidossessi Wilfried, et al.
Publicado: (2016)

Utility of a high VWF:FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice
por: Raquet, Elmar, et al.
Publicado: (2015)

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism
por: Bittar, Luis F., et al.
Publicado: (2015)

Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
por: Sung, Jin Jea, et al.
Publicado: (2019)

Determination of di-2-ethylhexyl phthalate levels in human blood plasma and cryoprecipitates.
por: Marcel, Y L
Publicado: (1973)

Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience
por: Sahoo, Dibyajyoti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fblu9g32nem24r52pn5dmim5b4